Product Images Paricalcitol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Paricalcitol NDC 55150-214 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

A long-term, open-label safety study of 164 CKD Stage 5 patients - paricalcitol fig1

A long-term, open-label safety study of 164 CKD Stage 5 patients - paricalcitol fig1

The text is a product label for a medication called Paricalcitol Injection. It contains 2 meg per mL for intravenous use and is manufactured in India for AuroMedis Pharma LLC in New Jersey. It is a single-dose vial containing 1mL of solution with 20% (v/v) alcohol.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 2 mcg/mL Container Label - paricalcitol fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 2 mcg/mL Container Label - paricalcitol fig2

This is a description of a medication labeled as Paricalcitol Injection, USP. It is intended for intravenous use, and each mL contains 2mg of Paricalcitol USP, with propylene glycol at 30% (vf) and alcohol at 20% (/). It is distributed by AuroMedics Pharma LLC and made in India. The usual dosage may be obtained from the package insert, and aseptic techniques must be used when handling the single-dose vials. The vial stoppers do not contain natural rubber latex.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2 mcg/mL Container-Carton (25 Vials) - paricalcitol fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2 mcg/mL Container-Carton (25 Vials) - paricalcitol fig3

This is a description of a prescription drug called Paricalcitol Injection, USP. It is manufactured in India by AuroMedis Pharma LLC for Rxonly and has an NDC code of 55150-213-01. The injection contains 5 mcg per mL and comes in a single-dose vial of 1 mL. The label advises that it is for intravenous use and contains 20% alcohol (v#).*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 5 mcg/mL Container Label - paricalcitol fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 5 mcg/mL Container Label - paricalcitol fig4

This is a product description for a medication with the NDC code 55150-213-01. The medication is an injection that contains Paricalcitol USP in a 5 meg per mL dose. The injection is for intravenous use only and is supplied in single-dose vials of 25 x 1 mL. The medication is produced by AuroMedics Pharma LLC and has a code of TSIDRUGS/ 132010. The medication should be stored at temperatures between 20° and 25°C. The stoppers of the vials are not made with natural rubber latex. The package insert should be consulted for full prescribing information.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mcg/mL Container-Carton (25 Vials) - paricalcitol fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 5 mcg/mL Container-Carton (25 Vials) - paricalcitol fig5

This is a description of a medication with the NDC code 55150-214-02, which is only available with a prescription. The medication contains 20% alcohol (v/v) and is manufactured in India by SETTEN TG AuroMedis Pharma LLC for SE Windsor. The medication comes in a single dose vial of 2mL and is intended for intravenous use. The dosage of the medication is 10mg per 2mL or 5mg per mL.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 10 mcg/2 mL (5 mcg/mL) [Single Dose Vial] - Container Label - paricalcitol fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 10 mcg/2 mL (5 mcg/mL) [Single Dose Vial] - Container Label - paricalcitol fig6

This is a description of a pharmaceutical product, Paricalcitol Injection, USP, used intravenously. The products come in 2mL single-dose vials, and each vial contains 10mg/2mL (5mg/mL) of Paricacitol USP, 30% (V/V) Propylene glycol, and 20% (V/V) alcohol. It should be stored at 20° to 25°C (68° to 77°F) and should be discarded after use. The package is distributed by AuroMedics Pharma LLC, made in India, and has a code of TS/DRUGS/132010. It also contains instructions on dosage and sterile techniques.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mcg/2 mL (5 mcg/mL) [Single Dose Vial] - Container-Carton (25 Vials) - paricalcitol fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mcg/2 mL (5 mcg/mL) [Single Dose Vial] - Container-Carton (25 Vials) - paricalcitol fig7

This is a description of a pharmaceutical product called R TITE 1 IC I manufactured by AuroMediis Pharma LLC. The product contains 10 mcg of an unknown substance per 2 mL of solution that is for intravenous use only. The solution is contained in a 2 mL multiple-dose vial and may contain 20% alcohol. The product has an NDC number of 55150-215-02 and was possibly manufactured in India. The text includes a lot number of P1430063.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 10 mcg/2 mL (5 mcg/mL) [Multi Dose Vial] - Container Label - paricalcitol fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 10 mcg/2 mL (5 mcg/mL) [Multi Dose Vial] - Container Label - paricalcitol fig8

Paricalcitol is an injection medication for intravenous use, distributed by AuroMedics Pharma LLC. The medication contains 10 mcg of Paricalcitol USP, along with propylene glycol and alcohol, and is available in a 25 x 2 mL multiple-dose vial. The usual dosage for the medication can be found in the package insert, and it is important to use aseptic technique when administering it. The vial stoppers are not made with natural rubber latex. Store the medication between 20°C to 25°C (68°F to 77°F).*

Paricalcitol Chemical Structure - paricalcitol str

Paricalcitol Chemical Structure - paricalcitol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.